EDITORIAL
Published on 09 Dec 2024
Editorial: Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes
doi 10.3389/fonc.2024.1519252
- 412 views
- Frontiers in Oncology
- Gynecological Oncology
- Research Topics
- Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes
Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes
10k
Total downloads
40k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 16 Aug 2024
Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes
doi 10.3389/fonc.2024.1408196
- 1,108 views
ORIGINAL RESEARCH
Published on 01 Aug 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial
doi 10.3389/fonc.2024.1404936
- 995 views
- 1 citation
CASE REPORT
Published on 15 Jul 2024
Growing teratoma syndrome of the ovary: a case report and literature review
doi 10.3389/fonc.2024.1412206
- 1,228 views
- 1 citation
REVIEW
Published on 04 Jun 2024
Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group
doi 10.3389/fonc.2024.1387281
- 2,865 views
- 2 citations
ORIGINAL RESEARCH
Published on 24 May 2024
Ovarian carcinosarcoma is highly aggressive compared to other ovarian cancer histotypes
doi 10.3389/fonc.2024.1399979
- 1,463 views
REVIEW
Published on 25 Apr 2024
Research progress in endometriosis-associated ovarian cancer
doi 10.3389/fonc.2024.1381244
- 2,357 views
- 2 citations
ORIGINAL RESEARCH
Published on 21 Mar 2024
Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients
doi 10.3389/fonc.2024.1370272
- 1,201 views
- 1 citation
ORIGINAL RESEARCH
Published on 07 Mar 2024
Trends in survival of ovarian clear cell carcinoma patients from 2000 to 2015
doi 10.3389/fonc.2024.1360663
- 1,981 views
ORIGINAL RESEARCH
Published on 14 Feb 2024
Bevacizumab increases the sensitivity of olaparib to homologous recombination-proficient ovarian cancer by suppressing CRY1 via PI3K/AKT pathway
doi 10.3389/fonc.2024.1302850
- 1,593 views
REVIEW
Published on 07 Feb 2024
New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment
doi 10.3389/fonc.2024.1329133
- 3,040 views
- 3 citations
CASE REPORT
Published on 02 Feb 2024
High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report
doi 10.3389/fonc.2023.1307573
- 2,363 views
- 1 citation
